{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T00:53:19.036036+00:00","published_at":"2026-10-16T13:54:58.592666+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/revolution-medicines-inc","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-16T13:54:58.592666+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:published_fact:4","stance":"supports"},{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:published_fact:5","stance":"supports"},{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:security_listing:19","stance":"supports"},{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:security_listing:20","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:legal_name:1","alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:entity_status:3","alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:published_fact:4","alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:published_fact:5","alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:security_listing:19","alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:security_listing:20"]},{"evidence_id":"alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","title":"Revolution Medicines DEF 14A 2025-04-29","identifier":null,"locator":null,"source_date":"2025-04-29","retrieved_at":"2026-04-30T20:20:01.357+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:6","stance":"supports"},{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:7","stance":"supports"},{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:8","stance":"supports"},{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:9","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:6","alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:7","alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:8","alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:9"]},{"evidence_id":"alpha:projection-evidence:document:31af6fc4cb28e2df1a6a537fa5149fd1183bf0374da56b3c92a57d8b0e451868","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"RVMD executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:10","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:10"]},{"evidence_id":"alpha:projection-evidence:document:2ffa8480ab4d1c6888ecd1964b286df595d44d23e9028db2246ac257b7420e1b","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"RVMD executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:11","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:11"]},{"evidence_id":"alpha:projection-evidence:document:112363363654bc2e8da89cff1e41b279978c86ecb9bf3820ab8a2ddb3d43dc6f","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"RVMD executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:12","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:12"]},{"evidence_id":"alpha:projection-evidence:document:9628b9946166c98323db9fb578bca7e0a071a20893b734ca6a6cef02b31e43e2","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"RVMD executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.954118+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:13","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:13"]},{"evidence_id":"alpha:projection-evidence:document:d31fdd026fe70bda79580f3082b7636343016f70f30c3628ca5203e890c768dd","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"RVMD executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:14","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:14"]},{"evidence_id":"alpha:projection-evidence:document:8dc70a9e8d42817db9a9825ad7516edf00703da1aed895b17f0a33731372a0e0","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"RVMD executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:15","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:15"]},{"evidence_id":"alpha:projection-evidence:document:5886d025130f6f506106daf774f43234dc74b182198215d938b1b42352f155ec","aliases":[],"source_type":"sec_filing","source_family":"unknown","publisher":null,"url":null,"title":"RVMD executive roster source","identifier":null,"locator":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"unknown","score":20,"source_family":"unknown","reasons":["No governed source-family rule matched."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:16","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:16"]},{"evidence_id":"alpha:projection-evidence:d6a9f2c71627b791a309835000fd694851e412fe9572a66b79b53ccd91403ff8","aliases":[],"source_type":"board_seats","source_family":"sec","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","title":"Compensation","identifier":null,"locator":null,"source_date":null,"retrieved_at":null,"content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:committee_record:17","stance":"supports"},{"claim_id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:committee_appointment:18","stance":"supports"}],"claim_ids":["alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:committee_record:17","alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:committee_appointment:18"]}]},"claims":[{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:legal_name:1","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Revolution Medicines, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"Revolution Medicines, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/revolution-medicines-inc","source_date":null,"retrieved_at":"2026-10-16T13:54:58.592666+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:entity_status:3","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/revolution-medicines-inc","source_date":null,"retrieved_at":"2026-10-16T13:54:58.592666+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:published_fact:4","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/revolution-medicines-inc","source_date":null,"retrieved_at":"2026-10-16T13:54:58.592666+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:published_fact:5","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:sector","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Healthcare","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"Healthcare","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/revolution-medicines-inc","source_date":null,"retrieved_at":"2026-10-16T13:54:58.592666+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:6","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:frank-k-clyburn-jr","object_label":"Frank K. Clyburn, Jr.","object_source_name_forms":[],"value":"Frank K. Clyburn, Jr.: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:frank-k-clyburn-jr","name":"Frank K. Clyburn, Jr."},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Revolution Medicines DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-30T20:20:01.357+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:7","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sandra-j-horning-m-d","object_label":"Sandra J. Horning, M.D.","object_source_name_forms":[],"value":"Sandra J. Horning, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sandra-j-horning-m-d","name":"Sandra J. Horning, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Revolution Medicines DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-30T20:20:01.357+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:8","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sushil-patel-ph-d","object_label":"Sushil Patel, Ph.D.","object_source_name_forms":[],"value":"Sushil Patel, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sushil-patel-ph-d","name":"Sushil Patel, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Revolution Medicines DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-30T20:20:01.357+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:9","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:thilo-schroeder-ph-d","object_label":"Thilo Schroeder, Ph.D.","object_source_name_forms":[],"value":"Thilo Schroeder, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:thilo-schroeder-ph-d","name":"Thilo Schroeder, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Revolution Medicines DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-30T20:20:01.357+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:10","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:alan-sandler","object_label":"Alan Sandler","object_source_name_forms":[],"value":"Alan Sandler: Chief Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:alan-sandler","name":"Alan Sandler"},"title":"Chief Development Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:31af6fc4cb28e2df1a6a537fa5149fd1183bf0374da56b3c92a57d8b0e451868","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:11","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:anthony-mancini","object_label":"Anthony Mancini","object_source_name_forms":[],"value":"Anthony Mancini: Chief Global Commercialization Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:anthony-mancini","name":"Anthony Mancini"},"title":"Chief Global Commercialization Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:2ffa8480ab4d1c6888ecd1964b286df595d44d23e9028db2246ac257b7420e1b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:12","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jack-anders","object_label":"Jack Anders","object_source_name_forms":[],"value":"Jack Anders: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jack-anders","name":"Jack Anders"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:112363363654bc2e8da89cff1e41b279978c86ecb9bf3820ab8a2ddb3d43dc6f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:13","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jeffrey-cislini","object_label":"Jeffrey Cislini","object_source_name_forms":[],"value":"Jeffrey Cislini: Senior Vice President, General Counsel and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jeffrey-cislini","name":"Jeffrey Cislini"},"title":"Senior Vice President, General Counsel and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:9628b9946166c98323db9fb578bca7e0a071a20893b734ca6a6cef02b31e43e2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.954118+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:14","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:margaret-horn","object_label":"Margaret Horn","object_source_name_forms":[],"value":"Margaret Horn: Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:margaret-horn","name":"Margaret Horn"},"title":"Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:d31fdd026fe70bda79580f3082b7636343016f70f30c3628ca5203e890c768dd","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:15","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mark-a-goldsmith","object_label":"Mark A. Goldsmith","object_source_name_forms":[],"value":"Mark A. Goldsmith: Chief Executive Officer, President and Chair of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mark-a-goldsmith","name":"Mark A. Goldsmith"},"title":"Chief Executive Officer, President and Chair of the Board","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:8dc70a9e8d42817db9a9825ad7516edf00703da1aed895b17f0a33731372a0e0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:leadership_role:16","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:stephen-m-kelsey","object_label":"Stephen M. Kelsey","object_source_name_forms":[],"value":"Stephen M. Kelsey: President, Research and Development","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:stephen-m-kelsey","name":"Stephen M. Kelsey"},"title":"President, Research and Development","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:5886d025130f6f506106daf774f43234dc74b182198215d938b1b42352f155ec","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-05-03","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:committee_record:17","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair not stated; Members Frank K. Clyburn, Jr.","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":null,"members":[{"display_name":"Frank K. Clyburn, Jr.","person_slug":"frank-k-clyburn-jr","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:d6a9f2c71627b791a309835000fd694851e412fe9572a66b79b53ccd91403ff8","identity_scope":"representation_reference","source_type":"board_seats","title":"Compensation","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:committee_appointment:18","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasCommitteeAppointment","object_id":"alpha:person:frank-k-clyburn-jr","object_label":"Frank K. Clyburn, Jr.","object_source_name_forms":[],"value":"Frank K. Clyburn, Jr.: member, Compensation","claim_type":"committee_appointment","predicate_id":"alpha:predicate:committee_appointment","predicate_version":1,"machine_key":"committee_appointment","human_label":"Committee Appointment","governed_predicate":true,"machine_value":{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:frank-k-clyburn-jr","name":"Frank K. Clyburn, Jr."},"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:d6a9f2c71627b791a309835000fd694851e412fe9572a66b79b53ccd91403ff8","identity_scope":"representation_reference","source_type":"board_seats","title":"Compensation","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:security_listing:19","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"RVMD (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"RVMD","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/revolution-medicines-inc","source_date":null,"retrieved_at":"2026-10-16T13:54:58.592666+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:50180d65-4ddf-4c80-a90f-01318bb24d83:security_listing:20","subject_id":"alpha:company:50180d65-4ddf-4c80-a90f-01318bb24d83","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"RVMDW (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"RVMDW","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/revolution-medicines-inc","source_date":null,"retrieved_at":"2026-10-16T13:54:58.592666+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:e947691d31aa14087fbde0d070bfee694b1124403cc1ea2378339cfa976ee32c","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/revolution-medicines-inc","source_date":null,"retrieved_at":"2026-10-16T13:54:58.592666+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4acaff52cb3ca02cb6c00aea4f95559651ef1e9f92da4abcf24de303f1b415e0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Revolution Medicines DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-30T20:20:01.357+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:31af6fc4cb28e2df1a6a537fa5149fd1183bf0374da56b3c92a57d8b0e451868","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:2ffa8480ab4d1c6888ecd1964b286df595d44d23e9028db2246ac257b7420e1b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:112363363654bc2e8da89cff1e41b279978c86ecb9bf3820ab8a2ddb3d43dc6f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9628b9946166c98323db9fb578bca7e0a071a20893b734ca6a6cef02b31e43e2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.954118+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d31fdd026fe70bda79580f3082b7636343016f70f30c3628ca5203e890c768dd","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:8dc70a9e8d42817db9a9825ad7516edf00703da1aed895b17f0a33731372a0e0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5886d025130f6f506106daf774f43234dc74b182198215d938b1b42352f155ec","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RVMD executive roster source","publisher":null,"url":null,"source_date":"2026-05-03","retrieved_at":"2026-05-03T15:43:35.678848+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:d6a9f2c71627b791a309835000fd694851e412fe9572a66b79b53ccd91403ff8","identity_scope":"representation_reference","source_type":"board_seats","title":"Compensation","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525103947/d942361ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.767,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.5,"cross_source_agreement":0.75,"temporal_completeness":0.333},"diagnostics":{"published_claims":19,"factual_claims":19,"claims_with_linked_evidence":19,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":12,"temporal_claims_with_valid_from":4,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:54:58.592666+00:00","observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":"2026-10-16T13:54:58.592666+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/revolution-medicines-inc/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/revolution-medicines-inc?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}